126
Participants
Start Date
March 14, 2018
Primary Completion Date
February 26, 2021
Study Completion Date
June 7, 2024
Parsaclisib
Parsaclisib tablets administered orally with water and without regard to food
University Hospital Kralovkse Vinohrady, Prague
Aou Citta Della Salute E Della Scienza Di Torino, Torino
Clinical Research Alliance, Inc., New Hyde Park
Karolinska University Hospital, Huddinge, Stockholm
Fakultni Nemocnice V Motole, Prague
University of Pennsylvania Health System, Philadelphia
Ospedale San Raffaele, Milan
Fondazione Irccs Istituto Nazionale Dei Tumori, Milan
Saint Agnes Hospital, Baltimore
Duke University Medical Center, Durham
Hgu Gregorio Maranon, Madrid
Md Anderson Cancer Centre Madrid, Madrid
Hospital Universitario Ramon Y Cajal, Madrid
Hospital Universitario de La Paz, Madrid
Hospital Universitario Hm Sanchinarro, Madrid
Aou Maggiore Della Carita, Novara
Hospital Universitario Quironsalud Madrid, Madrid
Charleston Hematology Oncology Associates Pa, Charleston
Rambam Medical Center, Haifa
Irccs Centro Di Riferimento Oncologico, Aviano
Florida Cancer Specialists & Research Institute, Fort Myers
Asclepes Research Centers, Spring Hill
San Bartolo Hospital, Vicenza
Tennessee Oncology, Nashville
Hillel Yafe Medical Center (Hymc), Hadera
Hospital Universitario de Canarias, San Cristóbal de La Laguna
Hattiesburg Clinic Hematology, Hattiesburg
University of Bologna, Bologna
Hospital Universitario Virgen Macarena, Seville
Hospital Universitario Virgen Del Rocio, Seville
A.O.U. Di Modena - Policlinico, Modena
Laniado Hospital Hematology, Netanya
Gabrail Cancer Center, Canton
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori, Meldola
Barbara Ann Karmanos Cancer Hospital, Detroit
Sheba Medical Center, Ramat Gan
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz
Saint Luke'S Hospital, Kansas City
Sarah Cannon Research Institute, Kansas City
Tel Aviv Sourasky Medical Center, Tel Aviv
University Hospital Mannheim, Mannheim
Istituto Tumori Giovanni Paolo Ii Irccs Ospedale Oncologico Bari, Bari
Clinical Trials of Swla Llc, Lake Charles
I.R.C.C.S. Casa Sollievo Della Sofferenza, San Giovanni Rotondo
Renovatio Clinical Consultants Llc, Spring
University Medical Center Freiburg, Freiburg im Breisgau
A.O.U. Federico Ii, Napoli
Arizona Oncology Associates - Biltmore Cancer Center, Phoenix
Synergy Hematology and Oncology Medical Associates, Los Angeles
Ospedali Riuniti Villa Sofia Cervello, Palermo
Beverly Hills Cancer Center, Beverly Hills
American Institute of Research Corporate Office, Whittier
St. Joseph Heritage Healthcare, Santa Rosa
University of Washington, Seattle
Cancer Center of Central Connecticut, Southington
Western Health, St Albans
Border Medical Oncology, Wodonga
St Vincent'S Hospital Sydney, Darlinghurst
Saint John Regional Hospital, Saint John
Sunnybrook Health Science Centre, Toronto
Santa Cabrini Hospital, Montreal
University Hospital Hradec Kralove, Hradec Králové
Fakultni Nemocnice Ostrava, Ostrava
Univerzita Karlova V Praze 1. Lekarska Fakulta, Prague
Aalborg University Hospital, Aalborg
Odense Universitetshospital (Ouh) (Odense University Hospital), Odense C
Bag Arnoldstr. Dresden, Dresden
Semmelweis Egyetem, Budapest
National Institute of Oncology, Budapest
University of Debrecen, Debrecen
Somogy Medyei Kaposi Mor Oktato Korhaz, Kaposvár
Sapienza University, Rome
Uniwersyteckie Centrum Kliniczne, Gdansk
Pratia McM Krakow, Krakow
State Hospital Opole, Opole
Institute of Hematology and Transfusion Medicine, Warsaw
Centrum Onkologii-Instytut Im. Marii Sklodowskiej-Curie, Warsaw
Hospital de La Santa Creu I Sant Pau, Barcelona
Hospital General Universitari Vall D Hebron, Barcelona
Birmingham Heartlands Hospital, Birmingham
Northwick Park Hospital, London
Royal Hallamshire Hospital, Sheffield
The Royal Marsden Nhs Foundation Trust - Chelsea, Sutton
Lead Sponsor
Incyte Corporation
INDUSTRY